Home / Lanreotide / Germany
DE ATC H01CB03 · updated 2 Nov 2026
Lanreotide shortage in Germany
Is there a Lanreotide shortage in Germany?
Yes. As of 2 Nov 2026, 2 Lanreotide products are reported short in Germany, the first since 9 Nov 2025. The company estimate for the return is 2 Feb 2027. Main reason: manufacturing problem.
Also short in Italy, Spain, Austria, Norway, Australia. All countries.
Affected products in Germany
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| DE | Mytolac 60 mg Injektionslösung in einer Fertigspritze | Amdipharm Limited | 9 Nov 2025 | 2 Feb 2027 | Manufacturing problem Probleme bei der Endfreigabe |
| DE | Mytolac 60 mg Injektionslösung in einer Fertigspritze | Amdipharm Limited | 9 Nov 2025 | 2 Feb 2027 | Manufacturing problem Probleme bei der Endfreigabe |
Source
BfArM (Federal Institute for Drugs and Medical Devices), via PharmNet.Bund. Official list. Supply-relevant medicines reported under a voluntary self-commitment; mostly hospital-relevant products.